Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-01 @ 4:26 PM
Study NCT ID:
NCT01711632
Status:
COMPLETED
Last Update Posted:
2025-10-20
First Post:
2012-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-17
First Submit QC Date:
None
Study First Post Date:
2012-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-08-04
Results First Submit QC Date:
None
Results First Post Date:
2025-10-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-07
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED